Characterizing CAR T Cell Therapy Biomarkers Through Multianalyte Analysis
Scientific Meeting PostersScientific Meeting Posters Summary
To unlock the vast potential of chimeric antigen receptor (CAR) T cell therapy, it is essential to explore the identification and surveillance of biomarkers linked to T cell activation and associated cytokine release syndrome (CRS).
Request Literature
To access this literature content please fill out the form below.